7-Oct-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Biology
Genomics & Genetics
Medical Genetics
Browse
ALL OF BIOLOGY
Genomics & Genetics
Animal Genetics
Bioinformatics
Evolutionary/Comparative Genetics
Genomics
Medical Genetics
Related Sections
Cell Growth & Division
Control of Gene Expression
Genetics of the Immune System
Microbial Evolution & Genomics
Nuclear Structure & Function
Pharmacogenomics
Physiogenomics
Plant Genetics & Gene Expression
Plant Genomes & Evolution
selected for
My F1000 Biology
Browse > Genomics & Genetics > Medical Genetics
Top 10
/
All time Top 10
/
Most viewed
/
Hidden jewels
Page 1 of 51. Select Page:
1
2
3
4
5
6
7
8
9
10
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
confirmations
controversial
dissenting
drug target
hypotheses
new findings
refutation
tech advances
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Recommended
F1000 Factor
3.0
New Finding
Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels.
Watase K, Barrett CF, …, Tsien RW, Zoghbi HY
Proc Natl Acad Sci U S A
2008 Aug 19
105
(33):11987-92 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Annette Dolphin
Evaluated 6 Oct 2008
Recommended
F1000 Factor
3.0
Hypothesis
Tech Advance
Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification.
Maeder ML, Thibodeau-Beganny S, …, Voytas DF, Joung JK
Mol Cell
2008 Jul 25
31
(2):294-301 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Brian Kuhlman
Evaluated 3 Oct 2008
Recommended
F1000 Factor
3.0
New Finding
Pharmacogenetics of cyclosporine in children suggests an age-dependent influence of ABCB1 polymorphisms.
Fanta S, Niemi M, …, Hoppu K, Backman JT
Pharmacogenet Genomics
2008 Feb
18
(2):77-90 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| J. Steven Leeder
Evaluated 3 Oct 2008
Recommended
F1000 Factor
3.0
New Finding
Solid-state NMR reveals structural differences between fibrils of wild-type and disease-related A53T mutant alpha-synuclein.
Heise H, Celej MS, …, Jovin TM, Baldus M
J Mol Biol
2008 Jul 11
380
(3):444-50 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Stephen Eyles
Evaluated 1 Oct 2008
Must Read
F1000 Factor
6.0
Hypothesis
New Finding
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
To MD, Wong CE, …, Di Lauro R, Balmain A
Nat Genet
2008 Oct
40
(10):1240-4 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Valeri Vasioukhin
Evaluated 30 Sep 2008
Recommended
F1000 Factor
3.0
New Finding
Tech Advance
Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs.
Rogers CS, Stoltz DA, …, Prather RS, Welsh MJ
Science
2008 Sep 26
321
(5897):1837-41 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| William H. Colledge
Evaluated 30 Sep 2008
Recommended
F1000 Factor
3.0
Hypothesis
Evolution of genomic imprinting with biparental care: implications for Prader-Willi and Angelman syndromes.
Ubeda F
PLoS Biol
2008 Aug 26
6
(8):e208 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Russell Bonduriansky
Evaluated 29 Sep 2008
Must Read
F1000 Factor
4.8
New Finding
Novel Drug Target
Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection.
Soroceanu L, Akhavan A, Cobbs CS
Nature
2008 Sep 18
455
(7211):391-5 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Ulf Pettersson / Andrius Kazlauskas
First evaluation 29 Sep 2008 | Latest evaluation 30 Sep 2008
Recommended
F1000 Factor
3.0
New Finding
Novel Drug Target
A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition.
Torbett NE, Luna-Moran A, …, Shokat KM, Stokoe D
Biochem J
2008 Oct 1
415
(1):97-110 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Simon Cook
Evaluated 29 Sep 2008
Must Read
F1000 Factor
6.0
Hypothesis
New Finding
Novel Drug Target
PTEN-deficient cancers depend on PIK3CB.
Wee S, Wiederschain D, …, Yao YM, Lengauer C
Proc Natl Acad Sci U S A
2008 Sep 2
105
(35):13057-62 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Simon Cook
Evaluated 29 Sep 2008
top of page
Page 1 of 51. Select Page:
1
2
3
4
5
6
7
8
9
10
>>
Display
10
/
20
/
50
papers per page
© 1999-2008 Biology Reports Ltd unless otherwise stated
< info@f1000.com >
Terms and conditions
Legal info